|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | ||||||||||
| Current receivables – net (Note 4) | ||||||||||
| Nonrelated party | ||||||||||
| Related party | ||||||||||
| Total current receivables – net (Note 4) | ||||||||||
| Inventories, including deferred inventory costs (Note 5) | ||||||||||
| Current contract assets (Note 9) | ||||||||||
| All other current assets (Note 10) | ||||||||||
| Assets held for sale (Note 3) | ||||||||||
| Current assets | ||||||||||
| Property, plant, and equipment – net (Note 6) | ||||||||||
| Goodwill (Note 8) | ||||||||||
| Intangible assets – net (Note 8) | ||||||||||
| Contract and other deferred assets (Note 9) | ||||||||||
| Equity method investments (Note 11) | ||||||||||
| Deferred income taxes (Note 16) | ||||||||||
| All other assets (Note 10) | ||||||||||
| Total assets | ||||||||||
| Accounts payable and equipment project payables (Note 12) | ||||||||||
| Nonrelated party | ||||||||||
| Related party | ||||||||||
| Total accounts payable and equipment project payables (Note 12) | ||||||||||
| Contract liabilities and deferred income (Note 9) | ||||||||||
| All other current liabilities (Note 15) | ||||||||||
| Liabilities held for sale (Note 3) | ||||||||||
| Current liabilities | ||||||||||
| Long-term borrowings (Note 14) | ||||||||||
| Non-current compensation and benefits | ||||||||||
| All other liabilities (Note 15) | ||||||||||
| Total liabilities | ||||||||||
| Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 266,333,581 and 269,529,464 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Retained earnings | ||||||||||
| Treasury common stock, 12,663,683 and 8,397,266 shares at cost as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Net parent investment | ||||||||||
| Accumulated other comprehensive income (loss) – net attributable to GE Vernova (Note 17) | ||||||||||
| Total equity attributable to GE Vernova | ||||||||||
| Noncontrolling interests | ||||||||||
| Total equity | ||||||||||
| Total liabilities and equity |
Loading...
